Literature DB >> 2460774

Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.

I Fagervall1, D Kelder, S B Ross.   

Abstract

1. The inhibition of monoamine oxidase (MAO) by 4, alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12), two amine releasing compounds, within monoaminergic neurons in the rat hypothalamus and striatum in vivo was determined. This was performed by measuring the protection of MAO by the test compound against the irreversible inhibition produced by phenelzine. The MAO activity inside and outside monoaminergic synaptosomes in homogenates of brain tissue was measured in the absence and presence of selective uptake inhibitors at low concentrations of 14C-labelled 5-hydroxytryptamine, noradrenaline or dopamine. 2. It was found that H77/77 and H75/12 produced a pronounced protection against phenelzine within the serotonergic and noradrenergic neurons, whereas much less effect was observed outside these neurons. 3. It was shown that the protection by H75/12 within the serotonergic neurons was somewhat reduced in 5-HT depleted reserpinized rats and that the protection outside these neurons was abolished. Some of the protection of MAO might therefore have been brought about by 5-HT molecules released by H75/12. 4. The marked inhibition of MAO within serotonergic and noradrenergic neurons was counteracted by amine uptake inhibitors and is accordingly brought about by the high concentrations of the accumulated compounds. 5. In contrast to other neuron selective MAO inhibitors, H75/12 decreased the 5-HT concentration in the hypothalamus showing that the releasing effect dominated over the MAO inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460774     DOI: 10.1007/bf00174862

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.

Authors:  A Carlsson; H Corrodi; K Fuxe; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

2.  Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine.

Authors:  A Carlsson; H Corrodi; K Fuxe; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

3.  Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.

Authors:  A L Ask; I Fagervall; L Florvall; S B Ross; S Ytterborn
Journal:  Neuropharmacology       Date:  1986-01       Impact factor: 5.250

4.  Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action.

Authors:  L Florvall; I Fagervall; A L Ask; S B Ross
Journal:  J Med Chem       Date:  1986-11       Impact factor: 7.446

5.  Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.

Authors:  S B Ross; A L Renyi
Journal:  Neuropharmacology       Date:  1977-01       Impact factor: 5.250

6.  Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.

Authors:  A L Ask; I Fagervall; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

7.  A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.

Authors:  I Fagervall; S B Ross
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

8.  (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.

Authors:  A L Ask; K Högberg; L Schmidt; H Kiessling; S B Ross
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

9.  Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.

Authors:  A L Ask; I Fagervall; L Florvall; S B Ross; S Ytterborn
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

10.  Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.

Authors:  L Rényi; S B Ross
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1985-05
View more
  1 in total

Review 1.  Amphetamine Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Miguel Reyes-Parada; Patricio Iturriaga-Vasquez; Bruce K Cassels
Journal:  Front Pharmacol       Date:  2020-01-23       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.